Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alder Biopharmaceuticals, Inc.
Alder Biopharmaceuticals Announces Expanded Collaboration With Schering-Plough
June 26th, 2009
Alder Biopharmaceuticals, Inc., an emerging antibody therapeutics company, announced the expansion of its collaborative alliance with leading pharmaceutical company Schering-Plough Corporation (NYSE: SGP). The collaboration continues to be successful in identifying numerous high quality therapeutic monoclonal antibody lead candidates. Candidates with potential applications to Central Nervous System (CNS) disorders are being identified through the application of Alder's innovative high throughput antibody selection (ABS) system and yeast production system (Mab Xpress). These technologies are designed to identify and produce best-in-class antibodies rapidly and cost...
Source: Health Business Week (2009-06-26)
|
